Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study

PURPOSE: To investigate the changes in vitreous inflammatory and angiogenic cytokine levels, primarily interleukin-(IL)-6, following intravitreal injection of the 0.19 mg fluocinolone acetonide (FAc, ILUVIEN®) implant in patients with diabetic macular edema. METHODS: A single-center phase IV study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Deuchler, Svenja K., Schubert, Ralf, Singh, Pankaj, Chedid, Adonis, Kenikstul, Ninel, Scott, Julia, Kohnen, Thomas, Ackermann, Hanns, Koch, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325820/
https://www.ncbi.nlm.nih.gov/pubmed/35239010
http://dx.doi.org/10.1007/s00417-022-05564-2

Ejemplares similares

Ejemplares similares